Skip to main content

$1.65 0.05 (3.13%)

High

$1.65

Low

$1.57

Trades

224

Turnover

$153,470

Volume

95,157
30 June 2023 at 4:10pm
Register to track CGS and receive email alerts.

Value of FY21 Clinical Trials Sales Contracts up 15%

StockBot

416,823 posts

CGS released this announcement to the ASX on 7 July 2021, 8:29. The announcement is marked as price sensitive, and is 2 page(s) in length and 104.98kb in size.

You can view all announcements from CGS and see how they appear on a price chart on the announcements page.

At the date of this announcement, CGS was 0.002% short sold according to ASIC data. It was ranked the 652nd most shorted stock on the ASX. It is now ranked as the 433rd most shorted stock on the ASX with 0.089% of total shares short sold as of the latest reported data (19 June 2025).

Other Recent Announcements from CGS
Notification of cessation of securities - CGS 9 June 2023, 8:18
Update - Notification of buy-back - CGS 8 June 2023, 8:23
Update - Notification of buy-back - CGS 7 June 2023, 8:25
Value of FY21 Clinical Trials Sales Contracts up 15% 7 July 2021, 8:29
Change in substantial holding 25 June 2021, 12:23
Change in substantial holding from AEF 15 June 2021, 14:51
Loan Forgiven re US Governments Paycheck Protection Program 15 June 2021, 9:15
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track CGS and receive email alerts.